| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CRL - Creightons Plc | SELL | -28 @ USD 115.76 | USD -3,241 | The ETF sold 28 shares of CRL on 2025-04-24. The shares were previously bought for an average price of USD 169.681. The Creightons Plc shares were sold for -31.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,510 The average price that the ETF previously sold CRL share for is USD 193.363 which is higher than the selling price of USD 115.76 on 2025-04-24. |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 139.56 | USD -3,489 | The ETF sold 25 shares of DVA on 2025-04-24. The shares were previously bought for an average price of USD 155.636. The DaVita HealthCare Partners Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 402 The average price that the ETF previously sold DVA share for is USD 155.034 which is higher than the selling price of USD 139.56 on 2025-04-24. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 50.78 | USD -4,418 | The ETF sold 87 shares of TECH on 2025-04-24. The shares were previously bought for an average price of USD 66.4556. The Bio-Techne Corp shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,364 The average price that the ETF previously sold TECH share for is USD 71.5134 which is higher than the selling price of USD 50.78 on 2025-04-24. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 66.23 | USD -4,570 | The ETF sold 69 shares of HSIC on 2025-04-24. The shares were previously bought for an average price of USD 73.2213. The Henry Schein Inc shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 482 The average price that the ETF previously sold HSIC share for is USD 71.8362 which is higher than the selling price of USD 66.23 on 2025-04-24. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 67.53 | USD -4,997 | The ETF sold 74 shares of SOLV on 2025-04-24. The shares were previously bought for an average price of USD 74.4897. The Solventum Corp. shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of USD 515 The average price that the ETF previously sold SOLV share for is USD 71.3391 which is higher than the selling price of USD 67.53 on 2025-04-24. |
| MRNA - Moderna Inc | SELL | -184 @ USD 27.39 | USD -5,040 | The ETF sold 184 shares of MRNA on 2025-04-24. The shares were previously bought for an average price of USD 36.0762. The Moderna Inc shares were sold for -24.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,598 The average price that the ETF previously sold MRNA share for is USD 42.3931 which is higher than the selling price of USD 27.39 on 2025-04-24. |
| INCY - Incyte Corporation | SELL | -89 @ USD 58.97 | USD -5,248 | The ETF sold 89 shares of INCY on 2025-04-24. The shares were previously bought for an average price of USD 69.4768. The Incyte Corporation shares were sold for -15.1% lower than average price of previous purchases. This resulted in an overall loss of USD 935 The average price that the ETF previously sold INCY share for is USD 73.9593 which is higher than the selling price of USD 58.97 on 2025-04-24. |
| VTRS - Viatris Inc | SELL | -668 @ USD 8.03 | USD -5,364 | The ETF sold 668 shares of VTRS on 2025-04-24. The shares were previously bought for an average price of USD 10.4953. The Viatris Inc shares were sold for -23.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,647 The average price that the ETF previously sold VTRS share for is USD 12.2695 which is higher than the selling price of USD 8.03 on 2025-04-24. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 174 | USD -5,394 | The ETF sold 31 shares of UHS on 2025-04-24. The shares were previously bought for an average price of USD 189.385. The Universal Health Services Inc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 477 The average price that the ETF previously sold UHS share for is USD 196.31 which is higher than the selling price of USD 174 on 2025-04-24. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 95.13 | USD -6,469 | The ETF sold 68 shares of RVTY on 2025-04-24. The shares were previously bought for an average price of USD 113.209. The Revvity Inc. shares were sold for -16.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,229 The average price that the ETF previously sold RVTY share for is USD 115.827 which is higher than the selling price of USD 95.13 on 2025-04-24. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 184.27 | USD -7,187 | The ETF sold 39 shares of ALGN on 2025-04-24. The shares were previously bought for an average price of USD 190.071. The Align Technology Inc shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 226 The average price that the ETF previously sold ALGN share for is USD 218.658 which is higher than the selling price of USD 184.27 on 2025-04-24. |
| HOLX - Hologic Inc | SELL | -124 @ USD 58.29 | USD -7,228 | The ETF sold 124 shares of HOLX on 2025-04-24. The shares were previously bought for an average price of USD 67.5564. The Hologic Inc shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,149 The average price that the ETF previously sold HOLX share for is USD 72.9586 which is higher than the selling price of USD 58.29 on 2025-04-24. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 210.59 | USD -8,213 | The ETF sold 39 shares of WST on 2025-04-24. The shares were previously bought for an average price of USD 262.766. The West Pharmaceutical Services Inc shares were sold for -19.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,035 The average price that the ETF previously sold WST share for is USD 302.707 which is higher than the selling price of USD 210.59 on 2025-04-24. |
| BAX - Baxter International Inc | SELL | -280 @ USD 30.41 | USD -8,515 | The ETF sold 280 shares of BAX on 2025-04-24. The shares were previously bought for an average price of USD 33.3849. The Baxter International Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 833 The average price that the ETF previously sold BAX share for is USD 33.3542 which is higher than the selling price of USD 30.41 on 2025-04-24. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 82.58 | USD -9,249 | The ETF sold 112 shares of COO on 2025-04-24. The shares were previously bought for an average price of USD 89.6304. The The Cooper Companies, Inc. Common Stock shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 790 The average price that the ETF previously sold COO share for is USD 98.2213 which is higher than the selling price of USD 82.58 on 2025-04-24. |
| MOH - MOH | SELL | -30 @ USD 313.81 | USD -9,414 | The ETF sold 30 shares of MOH on 2025-04-24. The shares were previously bought for an average price of USD 308.668. The MOH shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 154 The average price that the ETF previously sold MOH share for is USD 313.285 so the ETF has sold 30 shares on 2025-04-24 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 313.81 | USD -9,414 | The ETF sold 30 shares of MOH on 2025-04-24. The shares were previously bought for an average price of USD 308.668. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 154 The average price that the ETF previously sold MOH share for is USD 313.285 so the ETF has sold 30 shares on 2025-04-24 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -80 @ USD 119.51 | USD -9,561 | The ETF sold 80 shares of BIIB on 2025-04-24. The shares were previously bought for an average price of USD 146.933. The Biogen Inc shares were sold for -18.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,194 The average price that the ETF previously sold BIIB share for is USD 160.37 which is higher than the selling price of USD 119.51 on 2025-04-24. |
| PODD - Insulet Corporation | SELL | -38 @ USD 259.38 | USD -9,856 | The ETF sold 38 shares of PODD on 2025-04-24. The shares were previously bought for an average price of USD 268.792. The Insulet Corporation shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 358 The average price that the ETF previously sold PODD share for is USD 261.861 which is higher than the selling price of USD 259.38 on 2025-04-24. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 228.58 | USD -10,286 | The ETF sold 45 shares of LH on 2025-04-24. The shares were previously bought for an average price of USD 241.073. The Laboratory Corporation of America Holdings shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 562 The average price that the ETF previously sold LH share for is USD 237.753 which is higher than the selling price of USD 228.58 on 2025-04-24. |
| WAT - Waters Corporation | SELL | -32 @ USD 340.7 | USD -10,902 | The ETF sold 32 shares of WAT on 2025-04-24. The shares were previously bought for an average price of USD 372.13. The Waters Corporation shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,006 The average price that the ETF previously sold WAT share for is USD 374.659 which is higher than the selling price of USD 340.7 on 2025-04-24. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 340.7 | USD -10,902 | The ETF sold 32 shares of WAT on 2025-04-24. The shares were previously bought for an average price of USD 372.13. The MULETFWATIMETFP shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,006 The average price that the ETF previously sold WAT share for is USD 374.659 which is higher than the selling price of USD 340.7 on 2025-04-24. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 175.87 | USD -10,904 | The ETF sold 62 shares of DGX on 2025-04-24. The shares were previously bought for an average price of USD 165.966. The Quest Diagnostics Incorporated shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 614 The average price that the ETF previously sold DGX share for is USD 161.046 so the ETF has sold 62 shares on 2025-04-24 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 101.5 | USD -11,064 | The ETF sold 109 shares of ZBH on 2025-04-24. The shares were previously bought for an average price of USD 107.711. The Zimmer Biomet Holdings Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 677 The average price that the ETF previously sold ZBH share for is USD 108.954 which is higher than the selling price of USD 101.5 on 2025-04-24. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1075 | USD -11,825 | The ETF sold 11 shares of MTD on 2025-04-24. The shares were previously bought for an average price of USD 1250.99. The Mettler-Toledo International Inc shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,936 The average price that the ETF previously sold MTD share for is USD 1249.62 which is higher than the selling price of USD 1075 on 2025-04-24. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1075 | USD -11,825 | The ETF sold 11 shares of MTD on 2025-04-24. The shares were previously bought for an average price of USD 1250.99. The AMUNDI EUR GOV 710 shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,936 The average price that the ETF previously sold MTD share for is USD 1249.62 which is higher than the selling price of USD 1075 on 2025-04-24. |
| STE - STERIS plc | SELL | -54 @ USD 226.35 | USD -12,223 | The ETF sold 54 shares of STE on 2025-04-24. The shares were previously bought for an average price of USD 221.782. The STERIS plc shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of USD 247 The average price that the ETF previously sold STE share for is USD 217.934 so the ETF has sold 54 shares on 2025-04-24 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 150.68 | USD -13,863 | The ETF sold 92 shares of IQV on 2025-04-24. The shares were previously bought for an average price of USD 194.65. The IQVIA Holdings Inc shares were sold for -22.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,045 The average price that the ETF previously sold IQV share for is USD 200.148 which is higher than the selling price of USD 150.68 on 2025-04-24. |
| DXCM - DexCom Inc | SELL | -216 @ USD 70.78 | USD -15,288 | The ETF sold 216 shares of DXCM on 2025-04-24. The shares were previously bought for an average price of USD 78.184. The DexCom Inc shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,599 The average price that the ETF previously sold DXCM share for is USD 74.0108 which is higher than the selling price of USD 70.78 on 2025-04-24. |
| A - Agilent Technologies Inc | SELL | -156 @ USD 107.02 | USD -16,695 | The ETF sold 156 shares of A on 2025-04-24. The shares were previously bought for an average price of USD 131.065. The Agilent Technologies Inc shares were sold for -18.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,751 The average price that the ETF previously sold A share for is USD 133.297 which is higher than the selling price of USD 107.02 on 2025-04-24. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -250 @ USD 67.08 | USD -16,770 | The ETF sold 250 shares of GEHC on 2025-04-24. The shares were previously bought for an average price of USD 85.7411. The GE HealthCare Technologies Inc. shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,665 The average price that the ETF previously sold GEHC share for is USD 82.5035 which is higher than the selling price of USD 67.08 on 2025-04-24. |
| CNC - Concurrent Technologies Plc | SELL | -275 @ USD 61.58 | USD -16,935 | The ETF sold 275 shares of CNC on 2025-04-24. The shares were previously bought for an average price of USD 60.2465. The Concurrent Technologies Plc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 367 The average price that the ETF previously sold CNC share for is USD 59.8304 so the ETF has sold 275 shares on 2025-04-24 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 267.83 | USD -17,409 | The ETF sold 65 shares of HUM on 2025-04-24. The shares were previously bought for an average price of USD 271.844. The Hummingbird Resources PLC shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 261 The average price that the ETF previously sold HUM share for is USD 282.92 which is higher than the selling price of USD 267.83 on 2025-04-24. |
| HUM - Humana Inc | SELL | -65 @ USD 267.83 | USD -17,409 | The ETF sold 65 shares of HUM on 2025-04-24. The shares were previously bought for an average price of USD 271.844. The Humana Inc shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 261 The average price that the ETF previously sold HUM share for is USD 282.92 which is higher than the selling price of USD 267.83 on 2025-04-24. |
| CAH - Cardinal Health Inc | SELL | -133 @ USD 135.84 | USD -18,067 | The ETF sold 133 shares of CAH on 2025-04-24. The shares were previously bought for an average price of USD 127.428. The Cardinal Health Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 1,119 The average price that the ETF previously sold CAH share for is USD 122.328 so the ETF has sold 133 shares on 2025-04-24 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -81 @ USD 236.1 | USD -19,124 | The ETF sold 81 shares of RMD on 2025-04-24. The shares were previously bought for an average price of USD 234.389. The ResMed Inc shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 139 The average price that the ETF previously sold RMD share for is USD 242.875 which is higher than the selling price of USD 236.1 on 2025-04-24. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 440.98 | USD -19,403 | The ETF sold 44 shares of IDXX on 2025-04-24. The shares were previously bought for an average price of USD 437.816. The IDEXX Laboratories Inc shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 139 The average price that the ETF previously sold IDXX share for is USD 428.899 so the ETF has sold 44 shares on 2025-04-24 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -323 @ USD 75.13 | USD -24,267 | The ETF sold 323 shares of EW on 2025-04-24. The shares were previously bought for an average price of USD 70.9987. The Edwards Lifesciences Corp shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of USD 1,334 The average price that the ETF previously sold EW share for is USD 69.3553 so the ETF has sold 323 shares on 2025-04-24 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -94 @ USD 282.39 | USD -26,545 | The ETF sold 94 shares of COR on 2025-04-24. The shares were previously bought for an average price of USD 252.432. The Cencora Inc. shares were sold for 11.9% higher than average price of previous purchases. This sale made a profit of USD 2,816 The average price that the ETF previously sold COR share for is USD 248.606 so the ETF has sold 94 shares on 2025-04-24 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -157 @ USD 204.45 | USD -32,099 | The ETF sold 157 shares of BDX on 2025-04-24. The shares were previously bought for an average price of USD 230.204. The Becton Dickinson and Company shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,043 The average price that the ETF previously sold BDX share for is USD 225.423 which is higher than the selling price of USD 204.45 on 2025-04-24. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 341.41 | USD -33,117 | The ETF sold 97 shares of HCA on 2025-04-24. The shares were previously bought for an average price of USD 336.267. The HCA Holdings Inc shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 499 The average price that the ETF previously sold HCA share for is USD 335.539 so the ETF has sold 97 shares on 2025-04-24 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 599.76 | USD -34,186 | The ETF sold 57 shares of REGN on 2025-04-24. The shares were previously bought for an average price of USD 710.547. The Regeneron Pharmaceuticals Inc shares were sold for -15.6% lower than average price of previous purchases. This resulted in an overall loss of USD 6,315 The average price that the ETF previously sold REGN share for is USD 768.349 which is higher than the selling price of USD 599.76 on 2025-04-24. |
| ZTS - Zoetis Inc | SELL | -244 @ USD 152.3 | USD -37,161 | The ETF sold 244 shares of ZTS on 2025-04-24. The shares were previously bought for an average price of USD 167.674. The Zoetis Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,751 The average price that the ETF previously sold ZTS share for is USD 174.795 which is higher than the selling price of USD 152.3 on 2025-04-24. |
| CVS - CVS Health Corp | SELL | -687 @ USD 65.92 | USD -45,287 | The ETF sold 687 shares of CVS on 2025-04-24. The shares were previously bought for an average price of USD 62.2977. The CVS Health Corp shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of USD 2,489 The average price that the ETF previously sold CVS share for is USD 58.0401 so the ETF has sold 687 shares on 2025-04-24 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -68 @ USD 688.43 | USD -46,813 | The ETF sold 68 shares of MCK on 2025-04-24. The shares were previously bought for an average price of USD 615.311. The McKesson Corporation shares were sold for 11.9% higher than average price of previous purchases. This sale made a profit of USD 4,972 The average price that the ETF previously sold MCK share for is USD 611.382 so the ETF has sold 68 shares on 2025-04-24 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 335.7 | USD -50,019 | The ETF sold 149 shares of CI on 2025-04-24. The shares were previously bought for an average price of USD 314.773. The Cigna Corp shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 3,118 The average price that the ETF previously sold CI share for is USD 322.653 so the ETF has sold 149 shares on 2025-04-24 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 428.79 | USD -53,599 | The ETF sold 125 shares of ELV on 2025-04-24. The shares were previously bought for an average price of USD 410.264. The Elevance Health Inc shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 2,316 The average price that the ETF previously sold ELV share for is USD 410.848 so the ETF has sold 125 shares on 2025-04-24 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 428.79 | USD -53,599 | The ETF sold 125 shares of ELV on 2025-04-24. The shares were previously bought for an average price of USD 410.264. The Elevance Health Inc shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 2,316 The average price that the ETF previously sold ELV share for is USD 410.848 so the ETF has sold 125 shares on 2025-04-24 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,105 @ USD 48.69 | USD -53,802 | The ETF sold 1105 shares of BMY on 2025-04-24. The shares were previously bought for an average price of USD 57.8105. The Bloomsbury Publishing Plc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 10,078 The average price that the ETF previously sold BMY share for is USD 56.9753 which is higher than the selling price of USD 48.69 on 2025-04-24. |
| MDT - Medtronic PLC | SELL | -698 @ USD 84.3 | USD -58,841 | The ETF sold 698 shares of MDT on 2025-04-24. The shares were previously bought for an average price of USD 88.9698. The Medtronic PLC shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,260 The average price that the ETF previously sold MDT share for is USD 86.6734 which is higher than the selling price of USD 84.3 on 2025-04-24. |
| SYK - Stryker Corporation | SELL | -186 @ USD 361.05 | USD -67,155 | The ETF sold 186 shares of SYK on 2025-04-24. The shares were previously bought for an average price of USD 380.167. The Stryker Corporation shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,556 The average price that the ETF previously sold SYK share for is USD 378.429 which is higher than the selling price of USD 361.05 on 2025-04-24. |
| DHR - Danaher Corporation | SELL | -348 @ USD 196.5 | USD -68,382 | The ETF sold 348 shares of DHR on 2025-04-24. The shares were previously bought for an average price of USD 219.06. The Danaher Corporation shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 7,851 The average price that the ETF previously sold DHR share for is USD 233.802 which is higher than the selling price of USD 196.5 on 2025-04-24. |
| DHR - Danaher Corporation | SELL | -348 @ USD 196.5 | USD -68,382 | The ETF sold 348 shares of DHR on 2025-04-24. The shares were previously bought for an average price of USD 219.06. The Danaher Corporation shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 7,851 The average price that the ETF previously sold DHR share for is USD 233.802 which is higher than the selling price of USD 196.5 on 2025-04-24. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 492.47 | USD -68,453 | The ETF sold 139 shares of VRTX on 2025-04-24. The shares were previously bought for an average price of USD 477.558. The Vertex Pharmaceuticals Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 2,073 The average price that the ETF previously sold VRTX share for is USD 480.902 so the ETF has sold 139 shares on 2025-04-24 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,085 @ USD 22.78 | USD -70,276 | The ETF sold 3085 shares of PFE on 2025-04-24. The shares were previously bought for an average price of USD 25.9487. The Pfizer Inc shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,775 The average price that the ETF previously sold PFE share for is USD 25.9463 which is higher than the selling price of USD 22.78 on 2025-04-24. |
| GILD - Guild Esports Plc | SELL | -678 @ USD 106.15 | USD -71,970 | The ETF sold 678 shares of GILD on 2025-04-24. The shares were previously bought for an average price of USD 102.679. The Guild Esports Plc shares were sold for 3.4% higher than average price of previous purchases. This sale made a profit of USD 2,353 The average price that the ETF previously sold GILD share for is USD 94.7357 so the ETF has sold 678 shares on 2025-04-24 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -801 @ USD 101.14 | USD -81,013 | The ETF sold 801 shares of BSX on 2025-04-24. The shares were previously bought for an average price of USD 98.5121. The Boston Scientific Corporation shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 2,105 The average price that the ETF previously sold BSX share for is USD 90.1062 so the ETF has sold 801 shares on 2025-04-24 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -801 @ USD 101.14 | USD -81,013 | The ETF sold 801 shares of BSX on 2025-04-24. The shares were previously bought for an average price of USD 98.5121. The MULSTRXSSXIMETFP shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 2,105 The average price that the ETF previously sold BSX share for is USD 90.1062 so the ETF has sold 801 shares on 2025-04-24 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 279.84 | USD -81,713 | The ETF sold 292 shares of AMGN on 2025-04-24. The shares were previously bought for an average price of USD 303.39. The Amgen Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,877 The average price that the ETF previously sold AMGN share for is USD 297.815 which is higher than the selling price of USD 279.84 on 2025-04-24. |
| TMO - Time Out Group plc | SELL | -208 @ USD 426.66 | USD -88,745 | The ETF sold 208 shares of TMO on 2025-04-24. The shares were previously bought for an average price of USD 529.615. The Time Out Group plc shares were sold for -19.4% lower than average price of previous purchases. This resulted in an overall loss of USD 21,415 The average price that the ETF previously sold TMO share for is USD 527.616 which is higher than the selling price of USD 426.66 on 2025-04-24. |
| ISRG - Intuitive Surgical Inc | SELL | -193 @ USD 508.13 | USD -98,069 | The ETF sold 193 shares of ISRG on 2025-04-24. The shares were previously bought for an average price of USD 544.365. The Intuitive Surgical Inc shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,993 The average price that the ETF previously sold ISRG share for is USD 531.182 which is higher than the selling price of USD 508.13 on 2025-04-24. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 79.84 | USD -109,780 | The ETF sold 1375 shares of MRK on 2025-04-24. The shares were previously bought for an average price of USD 92.6909. The Marks Electrical Group PLC shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 17,670 The average price that the ETF previously sold MRK share for is USD 99.6441 which is higher than the selling price of USD 79.84 on 2025-04-24. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 79.84 | USD -109,780 | The ETF sold 1375 shares of MRK on 2025-04-24. The shares were previously bought for an average price of USD 92.6909. The Merck & Company Inc shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 17,670 The average price that the ETF previously sold MRK share for is USD 99.6441 which is higher than the selling price of USD 79.84 on 2025-04-24. |
| ABT - Abbott Laboratories | SELL | -942 @ USD 129.38 | USD -121,876 | The ETF sold 942 shares of ABT on 2025-04-24. The shares were previously bought for an average price of USD 126.383. The Abbott Laboratories shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 2,823 The average price that the ETF previously sold ABT share for is USD 118.198 so the ETF has sold 942 shares on 2025-04-24 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -958 @ USD 180.37 | USD -172,794 | The ETF sold 958 shares of ABBV on 2025-04-24. The shares were previously bought for an average price of USD 192.741. The AbbVie Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,851 The average price that the ETF previously sold ABBV share for is USD 186.704 which is higher than the selling price of USD 180.37 on 2025-04-24. |
| JNJ - Johnson & Johnson | SELL | -1,307 @ USD 154.93 | USD -202,494 | The ETF sold 1307 shares of JNJ on 2025-04-24. The shares were previously bought for an average price of USD 157.663. The Johnson & Johnson shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,572 The average price that the ETF previously sold JNJ share for is USD 154.829 so the ETF has sold 1307 shares on 2025-04-24 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -499 @ USD 424.25 | USD -211,701 | The ETF sold 499 shares of UNH on 2025-04-24. The shares were previously bought for an average price of USD 531.88. The UnitedHealth Group Incorporated shares were sold for -20.2% lower than average price of previous purchases. This resulted in an overall loss of USD 53,707 The average price that the ETF previously sold UNH share for is USD 582.261 which is higher than the selling price of USD 424.25 on 2025-04-24. |
| LLY - Eli Lilly and Company | SELL | -427 @ USD 859.73 | USD -367,105 | The ETF sold 427 shares of LLY on 2025-04-24. The shares were previously bought for an average price of USD 837.839. The Eli Lilly and Company shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 9,347 The average price that the ETF previously sold LLY share for is USD 801.211 so the ETF has sold 427 shares on 2025-04-24 at a higher price than the previous selling average. |